Succinylcholine is a short-acting, depolarizing neuromuscular blocking agent (NMBA) used as an adjunct to general anesthesia to facilitate tracheal intubation and provide skeletal muscle relaxation. Applying the 80/20 rule, the core clinical essence of succinylcholine centers on its rapid mechanism, critical safety warnings, and precise dosing.

1. Core Mechanism & Pharmacokinetics (The "20%" Driving Action)

• Mechanism: Succinylcholine competes with acetylcholine (ACh) at cholinergic receptors on the motor end-plate, depolarizing the membrane. Resistant to acetylcholinesterase, it remains bound to inhibit repolarization, causing transient muscle fasciculations followed by flaccid paralysis.
• Paralysis Order: Affects facial and glottis muscles first, then ...